Zoetis said its Board appointed Stephanie Tilenius as a director on October 23, 2025, effective December 1, 2025. She will serve until her successor is appointed or qualified, or until her resignation or removal.

1. 01

   Zoetis said its Board appointed Stephanie Tilenius as a director on October 23, 2025, effective December 1, 2025. She will serve until her successor is appointed or qualified, or until her resignation or removal.

2. 02

   The company said the Board size will increase from 12 to 13 members along with Ms. Tilenius's appointment, with the change also effective December 1, 2025.

3. 03

   The company said Ms. Tilenius was not appointed under any arrangement or understanding with a third party, and there have been no related party transactions with her since the beginning of the last fiscal year that are reportable under Regulation S-K Item 404(a). It also said she will be eligible to participate in the non-employee director compensation program, and that the company will enter into its standard indemnification agreement with her.

4. 04

   In a press release, the company said Ms. Tilenius founded Vida Health, Inc. and served as its CEO from 2014 to 2023, and held senior positions at Google, PayPal and eBay. It said she currently serves on the boards of Seagate Technology Holdings plc and Papa, and is a Venture Advisor to the AI Fund.

Analysis scope · Filing body and confirmed press-release exhibitWe analyzed the filing body and confirmed exhibits. This is not a review of other exhibits, investor presentations or the full earnings call.

AI summarized the filing and translated the summary into English; it may differ from the original. For reference only, not investment advice. AI translated the published Korean report into English. Figures are copied as filed, not recalculated.

Original filing

The filing as submitted to SEC EDGAR. You can check the figures and statements of this summary against it.